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Abstract
Background—Numerous studies in behavioral economics have demonstrated that individuals 
are more sensitive to the prospect of a loss than a gain (i.e., loss aversion). Although loss aversion 
has been well described in “healthy” populations, little research exists in individuals with 
substance use disorders. This gap is notable considering the prominent role that choice and 
decision-making play in drug use. The purpose of this pilot study was to evaluate loss aversion in 
active cocaine users.
Methods—Current cocaine users (N = 38; 42% female) participated in this within-subjects 
laboratory pilot study. Subjects completed a battery of tasks designed to assess loss aversion for 
drug and non-drug commodities under varying risk conditions. Standardized loss aversion 
coefficients (λ) were compared to theoretically and empirically relevant normative values (i.e., λ 
= 2).
Results—Compared to normative loss aversion coefficient values, a precise and consistent 
decrease in loss aversion was observed in cocaine users (sample λ ≈ 1). These values were 
observed across drug and non-drug commodities as well as under certain and risky conditions.
Correspondence: William W. Stoops, 140 Medical Behavioral Science Building, Lexington, KY 40536-0086, 
william.stoops@uky.edu, Phone: 859-257-5383, Facsimile: 859-257-7684. 
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Conclusions—These data represent the first systematic study of loss aversion in cocaine-using 
populations and provide evidence for equal sensitivity to losses and gains or loss equivalence. 
Futures studies should evaluate the specificity of these effects to a history of cocaine use as well as 
the impact of manipulations of loss aversion on drug use to determine how this phenomenon may 
contribute to intervention development efforts.
Keywords
Behavioral Economics; Drug; Gamble; Prospect Theory
1. Introduction
The application of behavioral economics to drug use has advanced addiction science (Bickel 
et al., 2014; Hursh and Roma, 2013; MacKillop, 2016). For example, research on delay 
discounting has informed the etiology of substance use disorders and intervention efforts 
(Bickel et al., 2012, 2017; Washio et al., 2011). Exploration of other behavioral economic 
principles not traditionally studied in substance use may provide insight into the origins and 
persistence of maladaptive patterns of drug taking.
Loss aversion has received extensive attention in behavioral economics (Novemsky and 
Kahneman, 2005). Numerous studies have demonstrated that, all things being equal, losses 
tend to have a greater impact on behavior than gains as represented by the standardized 
coefficient, lambda (λ) (Kahneman and Tversky, 1979; Tversky and Kahneman, 1991, 
1992). Although this relationship may differ across paradigms and environmental contexts, 
this literature highlights the importance of framing outcomes as losses or gains on 
subsequent decision-making.
Few studies have examined loss aversion in clinical populations and even fewer have 
evaluated individuals with a substance use disorder. The primary method used to evaluate 
loss aversion in substance use is computational modeling of Iowa Gambling Task (IGT) 
performance. These studies have found that IGT performance is consistent with decreased 
loss aversion (e.g., Ahn et al., 2014; Fridberg et al., 2010; Vassileva et al., 2013). However, 
reliance on indirect methods not traditionally applied in behavioral economics makes 
comparisons across disciplines difficult. The lack of studies examining ecologically relevant 
drug commodities is also a limitation. This pilot study examined loss aversion in active 
cocaine users using a multi-method test battery that varied in risk and the commodity 
available (drug and non-drug).
2. Materials and Methods
2.1 Subjects
Thirty-eight subjects participated in this within-subjects study (Table 1). Recruitment 
included formal advertisement, community flyers, and word of mouth. All subjects 
underwent comprehensive screening (see Stoops et al., 2010). Diagnostic criteria for cocaine 
use disorder were assessed using the computerized Structured Clinical Interview for DSM-
IV. All subjects were non-treatment seeking and reported cocaine use verified by urinalysis.
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2.2 Procedure
Subjects had to provide an expired air sample negative for alcohol and a urine specimen 
negative for all substances except cocaine and THC prior to participation. Subjects could 
proceed if THC positive, but had to pass a standard field sobriety test to ensure they were not 
acutely intoxicated. Sessions took approximately one hour. Subjects were provided $30 at 
study onset for use in behavioral tasks. One choice from the non-drug valuation task was 
randomly selected and subjects received money, the commodity, or nothing depending on 
their decisions. Subjects were also told to respond carefully on the mixed gambles and risk 
aversion tasks because one trial from each would be randomly selected and compensation 
provided (or lost) based on that trial. In actuality, all subjects received $10 for these tasks. 
Subjects were informed of task outcomes at the end of the session to avoid differential 
responses based on the results. All drug commodities were hypothetical and no cocaine was 
received. This study was approved by the Institutional Review Board of the University of 
Kentucky and conducted in accordance with the Declaration of Helsinki.
2.3 Behavioral Measures
2.3.1 Valuation Task—A valuation task was used to determine loss aversion under certain 
conditions (Gachter et al., 2007; Kahneman et al., 1990). In the “Willingness-to-Accept” 
(WTA) condition, subjects were given a commodity (e.g., a mug) and asked to indicate the 
price(s) at which they would be willing to sell the commodity. The “Willingness-to-
Purchase” (WTP) condition was identical except that subjects were shown the commodity 
and asked at what price(s) they would purchase it. Price ranges were $0.50 to $10 in $0.50 
increments. In a novel cocaine valuation task, subjects were asked to make hypothetical 
decisions about purchasing or selling 1 g of cocaine for prices ranging from $10 to $200 in 
$10 increments. All other procedures were identical. Presentation order for WTA and WTP 
conditions was counterbalanced with approximately 30 minutes between tasks. The primary 
outcome was the WTA/WTP ratio (λ; Novemsky and Kahneman, 2005).
2.3.2 Mixed Gambles Task—A mixed gambles task was used to determine loss aversion 
under uncertain conditions (Tom et al., 2007). Subjects were asked if they would accept 
gambles offering a 50/50 chance of winning or losing variable monetary amounts. Gains 
ranged from $10 to $40 in $2 increments, whereas losses ranged from $5 to $20 in $1 
increments. These ranges were selected based on the original task variant (Tom et al., 2007). 
A novel cocaine version was used with identical procedures, but presenting hypothetical 
gains and losses of 0.2 to 2.0 g of cocaine in 0.2 g increments. The primary outcome was λ, 
calculated as λ = −βloss/βgain derived from the logistic regression of gain and loss 
magnitude on trial choice. Nine subjects were excluded because of model non-convergence 
(Money Task = 2; Cocaine Task = 4; Both Tasks = 3). In general, this reflected a propensity 
to accept every or nearly every gamble.
2.3.3 Risk Aversion Task—A risk aversion task measured general aversion towards 
outcome variability. Subjects were presented with 11 double or nothing gambles ranging 
from $2 to $50. Previous studies have used this measure to account for general aversion to 
risk over specific aversion to loss (De Martino et al., 2010).
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2.4 Data Analysis
One-sample t-tests were used to determine if λ differed from a population normative value 
of 2. This number was selected because it is the value proposed by theoretical accounts of 
loss aversion in non-clinical (i.e., normative) populations (Kahneman and Tversky, 1979; 
Novemsky and Kahneman, 2005; Tversky and Kahneman, 1992). This value also lies within 
the ranges described by meta-analyses on WTP/WTA disparities (Neumann and Böckenholt, 
2014; Sayman and Öncüler, 2005; Tunçel and Hammitt, 2014). Sensitivity analyses were 
conducted using a lower threshold suggested by one meta-analysis (1.49; Neumann and 
Böckenholt, 2014). Confidence intervals and individual data were evaluated for precision 
and margin of difference.
Risk, Commodity, and Risk x Commodity effects were evaluated using linear mixed-effects 
models in the lme4 package of R (Bates et al., 2015). Risk aversion and task order were 
included as covariates.
3. Results
3.1 Valuation Task
Figure 1 shows λ values for valuation tasks (i.e., black circles) and normative value 
comparators (i.e., dotted lines). Similar magnitude prices for selling (WTA) and buying 
(WTP) were observed, specified by λ values of approximately 1. One-sample t-tests 
indicated that λ values for the mug, p < .001, d = 1.13, and cocaine, p < .001, d = 1.48, were 
significantly lower than a normative value of 2. Similar outcomes were observed with a 
conservative threshold of 1.49, p values < .01. Confidence intervals indicated precision and 
individual subject data supported the consistency of this estimate, with a majority of subjects 
clustering around the value of 1.
Analyses using only the first task completed supported these conclusions. These tests did not 
reveal significant between-subject differences in prices for selling and buying conditions, 
Mug p = .49; Cocaine p = .55. Similar magnitude λ values were also observed when 
computed using median WTA and WTP values from this first-task only subset, λ: Mug = 
1.20; Cocaine = 1.17.
3.2 Mixed Gambles Task
Mean gamble acceptance rates were 65.5% (SD = 27.0%) for money and 47.8% (SD = 
24.0%) for cocaine. Figure 1 shows λ values on the gambles tasks (i.e., white squares). 
Subjects were equally sensitive to losses and gains, reflected by λ values of approximately 
1. One-sample t-tests supported this conclusion indicating a significant difference from 2 for 
money, p < .001, d = 1.53, and cocaine, p < .001, d = 1.55. Similar outcomes were observed 
when comparing to 1.49, p values < .01. Confidence intervals indicated estimate precision 
and individual subject data supported consistency.
3.3 Risk and Commodity Effects
No significant Risk, Commodity, or Risk by Commodity effects were observed, p values > .
29. Risk aversion and task order were also not significant covariates, p values > .28.
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3.4 Individual Differences
Loss aversion across all tasks was not related to income, ZKPQ-Impulsivity Subscale, DAST 
scores, risk aversion, or Cocaine Dependence, p values > .08.
4. Discussion
Cocaine users showed a reliable reduction in loss aversion when compared to theoretically 
and empirically relevant normative values. This loss equivalence, as indicated by λ of 1, was 
consistent across risk and commodity type. These data represent the first study on multiple 
dimensions of loss aversion in a substance-using population and suggest that reductions in 
loss aversion are associated with a history of cocaine use.
A control group was not examined in this pilot study. Nevertheless, large and significant 
differences were observed when comparing our sample to a normative value of 2 as well as a 
lower threshold value. This uniform response to gains and losses stands in contrast to a rich 
behavioral economic literature demonstrating that losses generally have a greater impact on 
behavior than gains (Tversky and Kahneman, 1991, 1992). The use of theoretically relevant 
and empirically supported normative values is important given the general failure to consider 
such population normative comparisons when evaluating cognitive-behavioral processes in 
substance-using populations (Hart et al., 2012). It is possible, however, that loss aversion is 
epiphenomenally related to other primary causal agent(s) associated with substance use 
disorders. For example, socioeconomic status (SES) is frequently connected to substance use 
(Galea and Vlahov, 2002; Gilman et al., 2003) and lower SES may be correlated with lower 
loss aversion (Gachter et al., 2007). Individual difference variables were not related to loss 
aversion. However, these outcomes may reflect sample homogeneity rather than population 
level relationships. Future studies specifically designed to investigate individual differences 
are needed to clarify these results.
A substantial proportion of data were excluded from the mixed gambles task due to 
problems with model convergence. Non-convergence occurred in most cases due to 
acceptance of every or nearly every gamble, which could be indicative of task confusion. 
These data could also indicate an extreme decrease in loss aversion in which any loss is 
ineffective for changing behavior. These gambling tasks differed in price range and 
qualitative nature (i.e., dollars versus grams). It is possible that a wider range of loss values 
would have produced higher rates of systematic responding. However, a recent study found 
that the gain/loss ranges used could influence λ (Walasek and Stewart, 2015). We selected 
those parameters that mostly closely resembled the original task for this pilot purpose. This 
range also produced loss aversion in the aforementioned study (λ = 1.79; Walasek and 
Stewart, 2015) as well as other demonstrations of loss aversion in healthy participants (λ = 
1.93; Tom et al., 2007). Thus, it is unlikely that the loss equivalence observed was due to this 
procedural variation. Another possibility is that some subjects showed extreme rates of 
gambling due to differential perceptions of the endowment received given that greater rates 
of risk-taking can occur following profits (i.e., “house money effect”; Thaler and Johnson, 
1990). The findings collectively suggest that future research should investigate 
methodological parameters designed to increase rates of systematic data, such as additional 
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training sessions, attention checks verifying engagement and understanding, and alternative 
gain/loss ranges.
Prospect theory and loss aversion were developed to explain deviations from choices guided 
by expected utility (Kahneman and Tversky, 1979). We observed behavior operating under 
conditions more consistent with expected utility hypotheses, namely an equal sensitivity to 
gains and losses under a variety of experimental conditions. Such decisions based on 
expected utility may be advantageous under certain contexts (e.g., investing). However, loss 
equivalence may also be harmful in other situations, such as when attention is needed to the 
consequences of drug use. In this way, rigid loss aversion may represent a behavioral 
mechanism underlying disadvantageous choice characteristic of substance use and 
incorporating strategies to shift loss aversion in a context-dependent manner may help 
modify undesirable drug-taking behavior. This possibility is not unwarranted given that loss 
aversion is sensitive to cognitive-regulation strategies (Sokol-Hessner et al., 2009). Research 
examining the functional relationship between loss aversion and substance use will be 
crucial for informing loss aversion’s role in intervention development efforts.
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Highlights
• Loss aversion was tested in active cocaine users
• Cocaine users showed equal sensitivity to losses and gains
• Performance was similar under uncertain (risky) and certain conditions
• Performance was similar for drug (cocaine) and non-drug commodities
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Figure 1. 
Loss aversion coefficients for valuation (black circles) and mixed gambles (white squares) 
tasks. Dotted lines are normative loss aversion value of 2 (thick dotted line) and lower bound 
estimate of 1.49 (thin dotted line). Top Panel: Estimates represent mean values and error 
bars represent 95% confidence intervals. Bottom Panel: Plotted are individual subject data 
for each task.
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Table 1
Subject Demographics and Drug Use Variables
Mean/Count SD
Age 45.7 5.8
Female 16 (42%)
Race
 Caucasian 7 (18%)
 African American 31 (82%)
Years of Education 12.1 1.5
Income $7155 $7479
ZKPQ 1.4 1.7
CPD 11.8 7.4
FTND 3.8 2.3
Alcoholic Drinks Per Week 14.6 17.0
MAST 8.4 8.8
DAST 10.2 5.6
Cocaine Use
 Days Used Per Month 15.7 9.2
 Money Spent Per Month $659.5 $701.0
 Lifetime Uses 3562.6 2715.6
 Years Used 20.3 8.3
 Cocaine Abuse 11 (28.9%)
 Cocaine Dependence 25 (65.8%)
Note. ZKPQ = Impulsivity Subscale of the Zuckerman-Kuhlman Personality Questionnaire; CPD = cigarettes per day; FTND = Fagerström 
Test for Nicotine Dependence; MAST = Michigan Alcohol Screening Test; DAST = Drug Abuse Screening Test.
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